|
2024-11-12 |
2024-11-08 |
PS
Planned sale
|
Conner Edward R.
Chief Medical Officer
Officer
|
2,117
-100.0%
15.00
USD 31,755
|
2,117
-100.0%
|
15.00
|
USD 31,755
|
|
|
2024-10-31 |
2024-10-29 |
S
Sale
|
BVF PARTNERS L P/IL
|
64,617
-26.8%
14.30
USD 924,023
|
64,617
-26.8%
|
14.30
|
USD 924,023
|
|
|
2024-10-31 |
2024-10-29 |
S
Sale
|
BVF PARTNERS L P/IL
|
396,963
-22.5%
14.30
USD 5,676,571
|
396,963
-22.5%
|
14.30
|
USD 5,676,571
|
|
|
2024-10-31 |
2024-10-29 |
S
Sale
|
BVF PARTNERS L P/IL
|
538,420
-23.1%
14.30
USD 7,699,406
|
538,420
-23.1%
|
14.30
|
USD 7,699,406
|
|
|
2024-10-30 |
2024-10-28 |
PS
Planned sale
|
Conner Edward R.
Chief Medical Officer
Officer
|
2,673
-100.0%
15.00
USD 40,095
|
2,673
-100.0%
|
15.00
|
USD 40,095
|
|
|
2024-09-20 |
2024-09-19 |
PS
Planned sale
|
Person Julie
CHIEF ADMINISTRATIVE OFFICER
Officer
|
9,497
-100.0%
14.29
USD 135,685
|
9,497
-100.0%
|
14.29
|
USD 135,685
|
|
|
2024-09-20 |
2024-09-19 |
PS
Planned sale
|
Conner Edward R.
Chief Medical Officer
Officer
|
4,790
-100.0%
15.00
USD 71,850
|
4,790
-100.0%
|
15.00
|
USD 71,850
|
|
|
2024-09-20 |
2024-09-18 |
PS
Planned sale
|
Person Julie
CHIEF ADMINISTRATIVE OFFICER
Officer
|
503
-100.0%
14.00
USD 7,042
|
503
-100.0%
|
14.00
|
USD 7,042
|
|
|
2024-06-28 |
2024-06-26 |
PS
Planned sale
|
Person Julie
CHIEF ADMINISTRATIVE OFFICER
Officer
|
10,000
-100.0%
12.46
USD 124,569
|
10,000
-100.0%
|
12.46
|
USD 124,569
|
|
|
2024-06-10 |
2024-06-07 |
S
Sale
|
Dittman Jennifer
Chief Development Oper Officer
Officer
|
494
-100.0%
14.17
USD 7,000
|
494
-100.0%
|
14.17
|
USD 7,000
|
|
|
2024-05-22 |
2024-05-20 |
S
Sale
|
Dittman Jennifer
Chief Development Oper Officer
Officer
|
1,042
-100.0%
14.00
USD 14,588
|
1,042
-100.0%
|
14.00
|
USD 14,588
|
|
|
2024-05-22 |
2024-05-20 |
S
Sale
|
Dittman Jennifer
Chief Development Oper Officer
Officer
|
1,042
-100.0%
14.00
USD 14,588
|
1,042
-100.0%
|
14.00
|
USD 14,588
|
|
|
2024-05-20 |
2024-05-16 |
PS
Planned sale
|
Dittman Jennifer
Chief Development Oper Officer
Officer
|
23,578
-100.0%
14.04
USD 331,066
|
23,578
-100.0%
|
14.04
|
USD 331,066
|
|
|
2024-05-10 |
2024-05-09 |
PS
Planned sale
|
Holles Natalie C.
CEO
Executive Director
|
20,222
-1.6%
12.18
USD 246,300
|
20,222
-1.6%
|
12.18
|
USD 246,300
|
|
|
2024-05-10 |
2024-05-09 |
PS
Planned sale
|
Holles Natalie C.
CEO
Executive Director
|
20,222
-1.6%
12.18
USD 246,300
|
20,222
-1.6%
|
12.18
|
USD 246,300
|
|
|
2024-04-15 |
2024-04-11 |
PS
Planned sale
|
Holles Natalie C.
CEO
Executive Director
|
13,558
-1.1%
12.19
USD 165,214
|
13,558
-1.1%
|
12.19
|
USD 165,214
|
|
|
2024-04-08 |
2024-04-04 |
PS
Planned sale
|
Person Julie
CHIEF ADMINISTRATIVE OFFICER
Officer
|
1,107
-100.0%
10.00
USD 11,070
|
1,107
-100.0%
|
10.00
|
USD 11,070
|
|
|
2023-12-07 |
2023-12-05 |
PS
Planned sale
|
Conner Edward R.
Chief Medical Officer
Officer
|
4,790
-100.0%
10.03
USD 48,062
|
4,790
-100.0%
|
10.03
|
USD 48,062
|
|
|
2023-12-07 |
2023-12-05 |
PS
Planned sale
|
Person Julie
Chief Administrative Officer
Officer
|
12,863
-100.0%
10.30
USD 132,484
|
12,863
-100.0%
|
10.30
|
USD 132,484
|
|
|
2022-12-22 |
2022-12-20 |
B
Purchase
|
BVF PARTNERS L P/IL
Large shareholder
|
9,597
+4.1%
4.11
USD 39,430
|
9,597
+4.1%
|
4.11
|
USD 39,430
|
|
|
2022-12-22 |
2022-12-20 |
B
Purchase
|
BVF PARTNERS L P/IL
Large shareholder
|
87,831
+5.2%
4.11
USD 360,862
|
87,831
+5.2%
|
4.11
|
USD 360,862
|
|
|
2022-12-22 |
2022-12-20 |
B
Purchase
|
BVF PARTNERS L P/IL
Large shareholder
|
116,635
+5.3%
4.11
USD 479,207
|
116,635
+5.3%
|
4.11
|
USD 479,207
|
|
|
2022-09-21 |
2022-09-19 |
B
Purchase
|
ORBIMED ADVISORS LLC
Non-Executive Director
Large shareholder
|
300,000
+5.5%
17.00
USD 5,100,000
|
300,000
+5.5%
|
17.00
|
USD 5,100,000
|
|
|
2022-09-21 |
2022-09-19 |
B
Purchase
|
Bonita David P
Non-Executive Director
Large shareholder
|
300,000
+5.5%
17.00
USD 5,100,000
|
300,000
+5.5%
|
17.00
|
USD 5,100,000
|
|
|
2022-09-19 |
2022-09-19 |
B
Purchase
|
Atlas Venture Fund XI, L.P.
Large shareholder
|
300,000
+3.0%
17.00
USD 5,100,000
|
300,000
+3.0%
|
17.00
|
USD 5,100,000
|
|
